346 related articles for article (PubMed ID: 26202300)
21. High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and Receptor for Advanced Glycation End Products.
Mazarati A; Maroso M; Iori V; Vezzani A; Carli M
Exp Neurol; 2011 Dec; 232(2):143-8. PubMed ID: 21884699
[TBL] [Abstract][Full Text] [Related]
22. Expression of the receptor for advanced glycation end products, a target for high mobility group box 1 protein, and its role in chronic recalcitrant rhinosinusitis with nasal polyps.
Dzaman K; Szczepanski MJ; Molinska-Glura M; Krzeski A; Zagor M
Arch Immunol Ther Exp (Warsz); 2015 Jun; 63(3):223-30. PubMed ID: 25503556
[TBL] [Abstract][Full Text] [Related]
23. High motility group box 1 (HMGB1) protein and its receptor for advanced glycation end products (RAGE) expression in chronic rhinosinusitis without nasal polyps.
Dzaman K; Zagor M; Molinska-Glura M; Krzeski A
Folia Histochem Cytobiol; 2015; 53(1):70-8. PubMed ID: 25772690
[TBL] [Abstract][Full Text] [Related]
24. Spinal HMGB1 participates in the early stages of paclitaxel-induced neuropathic pain via microglial TLR4 and RAGE activation.
Moraes TR; Veras FP; Barchuk AR; Nogueira ESC; Kanashiro A; Galdino G
Front Immunol; 2024; 15():1303937. PubMed ID: 38384464
[TBL] [Abstract][Full Text] [Related]
25. High-mobility group box 1 impairs airway epithelial barrier function through the activation of the RAGE/ERK pathway.
Huang W; Zhao H; Dong H; Wu Y; Yao L; Zou F; Cai S
Int J Mol Med; 2016 May; 37(5):1189-98. PubMed ID: 27035254
[TBL] [Abstract][Full Text] [Related]
26. Cysteinyl leukotriene receptor 2 drives lung immunopathology through a platelet and high mobility box 1-dependent mechanism.
Liu T; Barrett NA; Kanaoka Y; Buchheit K; Laidlaw TM; Garofalo D; Lai J; Katz HR; Feng C; Boyce JA
Mucosal Immunol; 2019 May; 12(3):679-690. PubMed ID: 30664709
[TBL] [Abstract][Full Text] [Related]
27. TLR4 as receptor for HMGB1 induced muscle dysfunction in myositis.
Zong M; Bruton JD; Grundtman C; Yang H; Li JH; Alexanderson H; Palmblad K; Andersson U; Harris HE; Lundberg IE; Westerblad H
Ann Rheum Dis; 2013 Aug; 72(8):1390-9. PubMed ID: 23148306
[TBL] [Abstract][Full Text] [Related]
28. Multi-walled carbon nanotube induces nitrative DNA damage in human lung epithelial cells via HMGB1-RAGE interaction and Toll-like receptor 9 activation.
Hiraku Y; Guo F; Ma N; Yamada T; Wang S; Kawanishi S; Murata M
Part Fibre Toxicol; 2016 Mar; 13():16. PubMed ID: 27026438
[TBL] [Abstract][Full Text] [Related]
29. The HMGB1-TLR4 axis contributes to myocardial ischemia/reperfusion injury via regulation of cardiomyocyte apoptosis.
Ding HS; Yang J; Chen P; Yang J; Bo SQ; Ding JW; Yu QQ
Gene; 2013 Sep; 527(1):389-93. PubMed ID: 23727604
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of HMGB1-RAGE in Kawasaki disease with coronary artery injury.
Qian B; Huang H; Cheng M; Qin T; Chen T; Zhao J
Eur J Med Res; 2020 Mar; 25(1):8. PubMed ID: 32183905
[TBL] [Abstract][Full Text] [Related]
31. HMGB1 Promotes Intraoral Palatal Wound Healing through RAGE-Dependent Mechanisms.
Tancharoen S; Gando S; Binita S; Nagasato T; Kikuchi K; Nawa Y; Dararat P; Yamamoto M; Narkpinit S; Maruyama I
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27886093
[TBL] [Abstract][Full Text] [Related]
32. Ectodomain Shedding of RAGE and TLR4 as a Negative Feedback Regulation in High-Mobility Group Box 1-Activated Aortic Endothelial Cells.
Yang WS; Kim JJ; Lee MJ; Lee EK; Park SK
Cell Physiol Biochem; 2018; 51(4):1632-1644. PubMed ID: 30497069
[TBL] [Abstract][Full Text] [Related]
33. Interplay between RAGE and TLR4 Regulates HMGB1-Induced Inflammation by Promoting Cell Surface Expression of RAGE and TLR4.
Zhong H; Li X; Zhou S; Jiang P; Liu X; Ouyang M; Nie Y; Chen X; Zhang L; Liu Y; Tao T; Tang J
J Immunol; 2020 Aug; 205(3):767-775. PubMed ID: 32580932
[TBL] [Abstract][Full Text] [Related]
34. Role of multiligand/RAGE axis in platelet activation.
Fuentes E; Rojas A; Palomo I
Thromb Res; 2014 Mar; 133(3):308-14. PubMed ID: 24296115
[TBL] [Abstract][Full Text] [Related]
35. Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression.
Morris-Rosenfeld S; Blessing E; Preusch MR; Albrecht C; Bierhaus A; Andrassy M; Nawroth PP; Rosenfeld ME; Katus HA; Bea F
Eur J Clin Invest; 2011 Nov; 41(11):1164-71. PubMed ID: 21418204
[TBL] [Abstract][Full Text] [Related]
36. Uric Acid Induces Endothelial Dysfunction by Activating the HMGB1/RAGE Signaling Pathway.
Cai W; Duan XM; Liu Y; Yu J; Tang YL; Liu ZL; Jiang S; Zhang CP; Liu JY; Xu JX
Biomed Res Int; 2017; 2017():4391920. PubMed ID: 28116308
[TBL] [Abstract][Full Text] [Related]
37. High-mobility group box-1 induces vascular remodelling processes via c-Jun activation.
Zabini D; Crnkovic S; Xu H; Tscherner M; Ghanim B; Klepetko W; Olschewski A; Kwapiszewska G; Marsh LM
J Cell Mol Med; 2015 May; 19(5):1151-61. PubMed ID: 25726846
[TBL] [Abstract][Full Text] [Related]
38. Platelet-derived high-mobility group box 1 promotes recruitment and suppresses apoptosis of monocytes.
Vogel S; Rath D; Borst O; Mack A; Loughran P; Lotze MT; Neal MD; Billiar TR; Gawaz M
Biochem Biophys Res Commun; 2016 Sep; 478(1):143-148. PubMed ID: 27449608
[TBL] [Abstract][Full Text] [Related]
39. Platelet CD40 Exacerbates Atherosclerosis by Transcellular Activation of Endothelial Cells and Leukocytes.
Gerdes N; Seijkens T; Lievens D; Kuijpers MJ; Winkels H; Projahn D; Hartwig H; Beckers L; Megens RT; Boon L; Noelle RJ; Soehnlein O; Heemskerk JW; Weber C; Lutgens E
Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):482-90. PubMed ID: 26821950
[TBL] [Abstract][Full Text] [Related]
40. High mobility group box 1 was associated with thrombosis in patients with atrial fibrillation.
Xu Q; Bo L; Hu J; Geng J; Chen Y; Li X; Chen F; Song J
Medicine (Baltimore); 2018 Mar; 97(13):e0132. PubMed ID: 29595637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
